Consistent with the absence of hyperglycemia, MTX-531 treatment also had no effect on blood insulin levels, unlike alpelisib, which elicited a significant rise in both plasma glucose and insulin levels (Fig. 6b). Here, INS is linked to Hyperglycemia.